Figure 1From: Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophreniaThe age-specific prevalence of metabolic syndrome (Adapted National Cholesterol Education Program Adult Treatment Panel (ATP III-A)) among Japanese outpatients and inpatients with schizophrenia. * Indicates a statistically significant (P < 0.05) difference from control.Back to article page